Pharmacology and therapeutic potential of the n-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in fish oils

Indian Journal of Pharmacology

Volumn 31, Issue 4, 1999, Pages 247-264

  Hazra, Avijit ^a   Tripathi, Santanu Kumar ^b   Ghosh, Amitabha ^c  

^a Comm Devmt Med U Docum Centre ^*  (India)

^b NRS MEDICAL COLLEGE   (India)

^c BOSE INSTITUTE   (India)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Hypertriglyceridemia; Polyunsaturated fatty acid

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ANTICOAGULATION; CARDIOVASCULAR EFFECT; CYTOTOXICITY; DIARRHEA; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG SCREENING; DRUG TOLERABILITY; ERUCTATION; HUMAN; NAUSEA; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0032882632     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic West-coast Eskimos. Acta Med Scand 1972;192:85-94.
2. Collier PM, Ursell A, Zaremba K, Payne CM, Staughton RC, Sanders T. Effect of regular consumption of oily fish compared with white fish on chronic plaque psoriasis. Eur J Clin Nutr 1993;47:251-4.
3. Ackman RG. Perspectives on eicosapentaenoic acid (EPA). N-3 News: Unsaturated Fatty Acids and Health 1986;1:1-4.
4. Omega-3 marine triglycerides. In: Reynolds JEF, editor. Martindale The Extra Pharmacopoeia. 31st ed. London. The Royal Pharmaceutical Society, 1996:1310-1.
5. Hardy SC, Kleinman RE. Fat and cholesterol in the diet of infants and young children: implications for growth, development, and long-term health. J Pediatr 1994;125(5 Pt 2):S69-S77.
6. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54: 438-63.
7. Liebich HM, Wirth C, Jakober B. Analysis of polyunsaturated fatty acids in blood serum after fish oil administration. J Chromat 1991;572:1-9.
8. Ikeda I, Imasato Y, Nagao H, et al. Lymphatic transport of eicosapentaenoic and do-cosahexaenoic acids as triglyceride, ethyl ester and free acid, and their effect on cholesterol transport in rats. Life Sci 1993;52:1371-9.
9. Beckermann B, Beneke M, Seitz I. Comparative bioavailability of eicosapentaenoic acid and docosahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers [in German]. Arzneimittelforschung 1990;40:700-4.
10. Krokan HE, Bjerve KS, Mork E. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. Biochim Biophys Acta 1993;1168:59-67.
11. Marsen TA, Pollok M, Oette K, Baldamus CA. Pharmacokinetics of omega-3-fatty acids during ingestion of fish oil preparations. Prostaglandins Leukot Essent Fatty Acids 1992;46:191-6.
12. Christensen MS, Hoy CE, Becker CC, Redgrave TG. Intestinal absorption and lymphatic transport of eicosapentaenoic (EPA), docosahexaenoic (DHA), and decanoic acids: dependence on intramolecular triacylglycerol structure. Am J Clin Nutr 1995;61:56-61.
13. Hansen RA, Ogilvie GK, Davenport DJ, et al. Duration of effects of dietary fish oil supplementation on serum eicosapentaenoic acid and docosahexaenoic acid concentrations in dogs. Am J Vet Res 1998;59:864-8.
14. Grimminger F, Fuhrer D, Papavassilis C, et al. Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis. Eur J Clin Invest 1993;23:706-15.
15. Nilsson A, Hjelte L, Strandvik B. Incorporation of dietary [14C]arachidonic acid and [3H]eicosapentaenoic acid into tissue lipids during absorption of a fish oil emulsion. J Lipid Res 1992;33:1295-305.
16. Nariai T, Greig NH, DeGeorge JJ, Genka S, Rapoport SI. Intravenously injected radiolabelled fatty acids image brain tumour phospholipids in vivo: differential uptakes of palmitate, arachidonate and docosahexaenoate. Clin Exp Metastasis 1993;11:141-9.
17. Alberghina M, Lupo G, Anfuso CD, Infarinato S. Differential transport of docosahexaenoate and palmitate through the blood-retina and blood-brain barrier of the rat. Neurosci Lett 1994;171:133-6.
18. Nilsson A, Becker W. Uptake and interconversion of plasma unesterified n-3 polyunsaturated fatty acids by the G1 tract of rats. Am J Physiol 1995;268(5 Pt 1):G732-8.
19. Hrelia S, Lopez Jimenez JA, Bordoni A, et al. Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either n-6 or n-3 fatty acid supplementation. Biochem Biophys Res Commun 1995;216:11-9.
20. Lee TH, Arm JP, Horton CE, Crea AE, Mencia-Huerta JM, Spur BW. Effects of dietary fish oil lipids on allergic and inflammatory diseases. Allergy Proc 1991;12:299-303.
21. Lokesh BR, Kinsella JE. Effects of n-3 polyunsaturated fatty acids on the reacylation of arachidonic acid in peritoneal macrophages. Prostaglandins Leukot Essent Fatty Acids 1994;51:235-9.
22. Miller C, Yamaguchi RY, Ziboh VA. Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids. Lipids 1989;24:998-1003.
23. Poisson JP, Dupuy RP, Sarda P, et al. Evidence that liver microsomes of human neonates desaturate essential fatty acids. Biochim Biophys Acta 1993;1167:109-13.
24. Descomps B, Rodriguez A. Essential fatty acids and prematurity: a triple experimental approach [in French]. C R Seances Soc Biol Fil 1995;189:781-96.
25. Rosenquist A, Holmer G. Nutritional value of micro-encapsulated fish oils in rats [in German]. Z Ernahrungswiss 1996;35:178-84.
26. Flaten H, Hostmark AT, Kierulf P, Lystad E, Trygg K, Bjerkedal T, Osland A. Fish-oil concentrate: effects on variables related to cardiovascular disease. Am J Clin Nutr 1990;52:300-6.
27. Green P, Fuchs J, Schoenfeld N, et al. Effects of fish-oil ingestion on cardiovascular risk factors in hyperlipidemic subjects in Israel: a randomized, double-blind crossover study [see comments]. Am J Clin Nutr 1990;52:1118-24. Comment in: Am J Clin Nutr 1991;54:610-1.
28. Green P, Fuchs J, Schoenfeld N, et al. Effects of fish-oil ingestion on cardiovascular risk factors in hyperlipidemic subjects in Israel: a randomized, double-blind crossover study [see comments]. Am J Clin Nutr 1990;52:1118-24. Comment in: Am J Clin Nutr 1991;54:610-1.
29. Terres W, Beil U, Reimann B, Tiede S, Bleifeld W. Low-dose fish oil in primary hypertriglyceridemia. A randomized placebo-controlled study [in German]. Z Kardiol 1991;80:20-4.
30. Franzen O, Geisel J, Hopp HW, Oette K, Hilger HH. Long-term effects of low dosage fish oil on serum lipids and lipoproteins [in German]. Med Klin 1993;88:134-8.
31. Eritsland J, Seljeflot I, Abdelnoor M, Arnesen H, Torjesen PA. Long-term effects of n-3 fatty acids on serum lipids and glycaemic control. Scand J Clin Lab Invest 1994;54: 273-80.
32. Herrmann W, Biermann J, Kostner GM. Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease. Am J Cardiol 1995;76:459-62.
33. Hamazaki T, Sawazaki S, Asaoka E, et al. Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults. J Nutr 1996;126:2784-9.
34. Schindler OS, Rost R. Effect of low dose omega-3 fatty acid supplementation on plasma lipids and lipoproteins in coronary patients with dyslipoproteinemia [in German]. Z Ernahrungswiss 1996;35:191-8.
35. Agren JJ, Hanninen O, Julkunen A, et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr 1996;50:765-71.
36. Carvajal O, Angulo O. Effect of n-3 polyunsaturated fatty acids on the lipidic profile of healthy Mexican volunteers. Salud Publica Mex 1997;39:221-4.
37. Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA, Drennan KB. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 1997;16:236-43.
38. Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS, Kyle D. The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 1997;32:1137-46.
39. Reuter W, Vorberg B, Sauer I, Krumpolt C. Changes in parameters of lipid metabolism and anti-oxidative potentials in elderly hyperlipoproteinemic patients treated with omega-3 fatty acids [in German]. Z Gerontol 1994;27:204-7.
40. Mori TA, Vandongen R, Beilin LJ, Burke V, Morris J, Ritchie J. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 1994;59:1060-8.
41. Sanders TA, Hinds A, Pereira CC. Influence of n-3 fatty acids on blood lipids in normal subjects. J Intern Med Suppl 1989;225:99-104.
42. Childs MT, King IB, Knopp RH. Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenolc acid and docosahexaenoic acid. Am J Clin Nutr 1990;52: 632-9.
43. Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K et al. Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia [in Italian]. Cardiologia 1993;38:773-8.
44. Li Y, Kang JX, Leaf A. Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 1997;54:511-30.
45. Yang BC, Saldeen TG, Bryant JL, Nichols WW, Mehta JL. Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J 1993;126:1287-92.
46. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 1993;58:666-9.
47. Leaf A, Kang JX. Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence. J Intern Med 1996;240:5-12.
48. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 1995;274:1363-7.
49. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. J Am Med Assoc 1998;279:23-8.
50. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 1994;91:4427-30.
51. Billman GE, Kang JX, Leaf A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 1997;32:1161-8.
52. Salachas A, Papadopoulos C, Sakadamis G, Styliadis J, Voudris V, Oakley D et al. Effects of a low-dose fish oil concentrate on angina, exercise tolerance time, serum triglycerides and platelet function. Angiology 1994;45:1023-31.
53. Aucamp AK, Schoeman HS, Coetzee JH. Pilot trial to determine the efficacy of a low dose of fish oil in the treatment of angina pectoris in the geriatric patient. Prostaglandins Leukot Essent Fatty Acids 1993;49:687-9.
54. Landmark K, Abdelnoor M, Urdal P, et al. Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology 1998;89:94-102.
55. Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 1995;76:974-7.
56. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival - 4. Cardiovasc Drugs Ther 1997;11:485-91.
57. Kromhout D, Bosschieter EB, Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
58. Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995;24:340-5.
59. Gusain D, Sharma I, Dixit VP. Antiatherosclerotic effects of fish extract feeding in rabbits. J Ethnopharmacol 1994;41:59-63.
60. Samsonov MA, Vasil'ev AV, Pogozheva AV, et al. The effect of a soy protein isolate and sources of polyunsaturated omega-3 fatty acids in an anti-atherosclerotic diet on the lipid spectrum of blood serum and immunological indicators in patients with ischemic heart disease and hypertension [in Russian]. Vopr Med Khim 1992;38:47-50.
61. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis: HARP Research Group. J Am Coll Cardiol 1995;25:1492-8.
62. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty: a meta-analysis. Arch Intern Med 1993;153: 1595-601.
63. Cairns JA, Gill J, Morton B, Roberts R, Gent M, Hirsh J et al. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty: the EMPAR Study. Circulation 1996;94: 1553-60.
64. Pyzh MV, Gratsianskii NA, Golubykh VL, Borovinkov DV, Barskaia NV. Food supplement containing omega-3 polyunsaturated fatty acids prevents experimental thrombotic occlusion of coronary arteries in dogs [in Russian]. Kardiologiia 1993;33:41-6.
65. Tsuruta K, Ogawa H, Yasue H, Sakamoto T, Miyao Y, Tanae H et al. Effect of purified eicosapentaenoate ethyl ester on fibrinolytic capacity in patients with stable coronary artery disease and lower extremity ischaemia. Coron Artery Dis 1996;7:837-42.
66. Liutova LV, Karabasova MA, Andreenko GV, Panchenko VM, Isaev VA, Sorokaletov SM et al. Effect of docanol on the status of hemostasis and fibrinolysis systems, as well as lipid spectrum in patients with ischemic heart disease depending on the initial level of fibrinolytic activity [in Russian]. Vopr Med Khim 1996;42:64-70.
67. Eritsland J, Arnesen H, Seljeflot I, Kierulf P. Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 1995;6:17-22.
68. Vaskonen T, Laakso J, Mervaala E, Sievi E, Karppanen H. Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat. Blood Press 1996;5:178-9.
69. Appel LJ, Miller ER III, Seidler AJ, Whelton PK. Does supplementation of diet with fish oil reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
70. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33.
71. Pogozheva AV, Samsonov MA, Levachev MM. Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension [in Russian]. Vopr Pitan 1996;(1):34-6.
72. McCarty MF. Fish oil and other nutritional adjuvants for treatment of congestive heart failure. Med Hypotheses 1996;46:400-6.
73. McCarty MF. Fish oil may be an antidote for the cardiovascular risk of smoking. Med Hypotheses 1996;46:337-47.
74. Rodriguez BL, Sharp DS, Abbott RD, Burchfiel CM, Masaki K, Chyou PH et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: the Honolulu Heart Program. Circulation 1996;94:952-6.
75. Saito M, Nakatsugawa K. Increased susceptibility of liver to lipid peroxidation after ingestion of a high fish oil diet. Int J Vitam Nutr Res 1994;64:144-51.
76. Laganiere S, Yu BP, Fernandes G. Studies on membrane lipid peroxidation in omega-3 fatty acid-fed autoimmune mice: effect of vitamin E supplementation. Adv Exp Med Biol 1990;262:95-102.
77. Allard JP, Kurian R, Aghdassi E, Muggli R, Royall D. Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids 1997;32:535-41.
78. Wander RC, Du SH, Ketchum SO, Rowe KE. Alpha-Tocopherol influences in vivo indices of lipid peroxidation in postmenopausal women given fish oil. J Nutr 1996;126:643-52.
79. Calzada C, Vericel E, Lagarde M. Lower levels of lipid peroxidation in human platelets incubated with eicosapentaenoic acid. Biochim Biophys Acta 1992;1127:147-52.
80. Demoz A, Willumsen N, Berge RK. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids 1992;27:968-71.
81. Supari F, Ungerer T, Harrison DG, Williams JK. Fish oil treatment decreases superoxide anions in the myocardium and coronary arteries of atherosclerotic monkeys. Circulation 1995;91:1123-8.
82. Pogozheva AV, Martynova EA, Samsonov MA, Egorova NI, Ksenofontova EA, Gorozhanskaia EG. Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension [in Russian]. Vopr Pitan 1994;(4):40-2.
83. Turley E, Wallace JM, Gilmore WS, Strain JJ. Fish oil supplementation with and without added vitamin E differentially modulates plasma antioxidant concentrations in healthy women. Lipids 1998;33:1163-7.
84. Oostenbrug GS, Mensink RP, Hardeman MR, De Vries T, Brouns F, Hornstra G. Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E. J Appl Physiol 1997;83:746-52.
85. Sen CK, Atalay M, Agren J, Laaksonen DE, Roy S, Hanninen O. Fish oil and vitamin E supplementation in oxidative stress at rest and after physical exercise. J Appl Physiol 1997;83:189-95.
86. Brown JE, Wahle KW. Effect of fish-oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta 1990;193:147-56.
87. Saito M, Kubo K, Ikegami S. An assessment of docosahexaenoic acid (DHA) intake with special reference to lipid metabolism in rats. J Nutr Sci Vitaminol (Tokyo) 1996;42: 195-207.
88. Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett 1991;56:235-43.
89. Burns CP, Wagner BA. Heightened susceptibility of fish oil polyunsaturate-enriched neoplastic cells to ethane generation during lipid peroxidation. J Lipid Res 1991;32:79-87.
90. Noding R, Schonberg SA, Krokan HE, Bjerve KS. Effects of polyunsaturated fatty acids and their n-6 hydroperoxides on growth of five malignant cell lines and the significance of culture media. Lipids 1998;33:285-93.
91. Finstad HS, Kolset SO, Holme JA, Wiger R, Farrants AK, Blomhoff R, Drevon CA. Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. Blood 1994;84:3799-809.
92. Sravan Kumar G, Das UN. Cytotoxic action of alpha-linolenic and eicosapentaenoic acids on myeloma cells in vitro. Prostaglandins Leukot Essent Fatty Acids 1997;56:285-93.
93. Sagar PS, Das UN. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins Leukot Essent Fatty Acids 1995;53:287-99.
94. Finstad HS, Drevon CA, Kulseth MA, Synstad AV, Knudsen E, Kolset SO. Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid. Biochem J 1998;336(Pt 2):451-9.
95. Abbott WG, Tezabwala B, Bennett M, Grundy SM. Melanoma lung metastases and cytolytic effector cells in mice fed antioxidant-balanced corn oil or fish oil diets. Nat Immun 1994;13:15-28.
96. Noguchi M, Rose DP, Earashi M, Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology 1995;52:265-71.
97. Craig-Schmidt M, White MT, Teer P, Johnson J, Lane HW. Menhaden, coconut, and corn oils and mammary tumor incidence in BALB/c virgin female mice treated with DMBA. Nutr Cancer 1993;20:99-106.
98. Shao Y, Pardini L, Pardini RS. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 1995;30:1035-45.
99. Kumaratilake LM, Robinson BS, Ferrante A, Poulos A. Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. J Clin Invest 1992;89:961-7.
100. Levander OA, Ager AL Jr, Morris VC, May RG. Plasmodium yoelii: comparative antimalarial activities of dietary fish oils and fish oil concentrates in vitamin E-deficient mice. Exp Parasitol 1990;70:323-9.
101. Washio M, Nanishi F, Onoyama K. Effects of fish oil rich in eicosapentaenoic acid on focal glomerulosclerosis of adriamycin-induced nephropathy in rats. Curr Therapeutic Res 1993;53:35-41.
102. Grauer GF, Greco DS, Behrend EN, Fettman MJ, Mani I, Getzy DM et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. Am J Vet Res 1996;57:948-56.
103. Homan van der Heide JJ, Bilo HJG, Donker JM, Wilmink JM, Tegzess AM. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 1993;329:769-73.
104. Busnach G, Stragliotto E, Minetti E, Perego A, Brando B, Broggi ML et al. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study. J Nephrol 1998;11:87-93.
105. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116:609-14.
106. Loeschke K, Ueberschaer B, Pietsch A, Gruber E, Ewe K, Wiebecke B et al. N-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 1996;41:2087-94.
107. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease - a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 1989;225:225-32.
108. Gupta AK, Ellis CN, Goldfarb MT, Hamilton TA, Voorhees JJ. The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis. Int J Dermatol 1990;29:591-5.
109. Henneicke-von Zepelin HH, Mrowietz U, Farber L, Bruck-Borchers K, Schober C, Huber J et al. Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study. Br J Dermatol 1993;129:713-7.
110. Frati C, Bevilacqua L, Apostolico V. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation. Acta Derm Venereol Suppl (Stockh) 1994;186:151-3.
111. Kurkcuoglu N, Tandogdu R. The effect of 'MaxEPA' in the treatment of patients with Behcet's disease. Br J Dermatol 1989;121:667-8.
112. DiGiacomo RA, et al. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. Am J Med 1989;86:158-64.
113. Ariza-Ariza R, Mestanza-Peralta M, Cardiel MH. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin Arthritis Rheum 1998;27:366-70.
114. Lawrence R, Sorrell T. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4. Lancet 1993;342:465-9.
115. Campan P, Planchand PO, Duran D. Polyunsaturated omega-3 fatty acids in the treatment of experimental human gingivitis [in French]. Bull Group Int Rech Sci Stomatol Odontol 1996;39:25-31.
116. Parks JS, Crouse JR. Reduction of cholesterol absorption by dietary oleinate and fish oil in African green monkeys. J Lipid Res 1992;33:559-68.
117. Mizuguchi K, Yano T, Tanaka Y, Ishibashi M, Masada A, Mizota M et al. Mechanism of the lipid-lowering effect of ethyl all-cis-5,8,11,14,17-icosapentaenoate. Eur J Pharmacol 1993;231:121-7.
118. Schectman G, Boerboom LE, Hannah J, Howard BV, Mueller RA, Kissebah AH. Dietary fish oil decreases low-density-lipoprotein clearance in nonhuman primates. Am J Clin Nutr 1996;64:215-21.
119. Leaf A, Kang JX. Dietary n-3 fatty acids in the prevention of lethal cardiac arrhythmias. Curr Opin Lipidol 1997;8:4-6.
120. (2+))-ATPase activity. Jpn Circ J 1994;58:903-12.
121. Kang JX, Leaf A. The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 1996;31(Suppl):S41-4.
122. Anderson KE, Du XJ, Sinclair AJ, Woodcock EA, Dart AM. Dietary fish oil prevents reperfusion Ins(1,4,5)P3 release in rat heart: possible antiarrhythmic mechanism. Am J Physiol 1996:271(4 Pt 2):H1483-90.
123. Chen MF, Hsu HC, Lee YT. Effects of fish oil supplementation on the changes in myocardial cyclic adenosine monophosphate, inositol 1,4,5-triphosphate and mitochondrial calcium levels during acute coronary occlusion-reperfusion in cholesterol-fed rabbits. Int J Cardiol 1994;46:23-31.
124. Demaison L, Sergiel JP, Moreau D, Grynberg A. Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1994; 1227:53-9.
125. McMillin JB, Bick RJ, Benedict CR. Influence of dietary fish oil on mitochondrial function and response to ischemia. Am J Physiol 1992;263(5 Pt 2):H1479-85.
126. Heemskerk JW, Vossen RC, van Dam-Mieras MC. Polyunsaturated fatty acids and function of platelets and endothelial cells. Curr Opin Lipidol 1996;7:24-9.
127. Santos MJ, Llopis J, Mataix FJ, Urbano G, Lopez Jurado M. Influence of dietary fish on fatty acid composition of the erythrocyte membrane in coronary heart disease patients. Int J Vitam Nutr Res 1996;66:378-85.
128. Crosby AJ, Wahle KW, Duthie GG. Modulation of glutathione peroxidase activity in human vascular endothelial cells by fatty acids and the cytokine interleukin-1 beta. Biochim Biophys Acta 1996;1303:187-92.
129. Calder PC. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz J Med Biol Res 1998;31:467-90.
130. Blok WL, Katan MB, van der Meer JW. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996;126:1515-33.
131. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217-24.
132. Sanderson P, Calder PC. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 1998;94:79-87.
133. Soyland E, Lea T, Sandstad B, Drevon A. Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases. Eur J Clin Invest 1994;24:236-42.
134. Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 1991;32:1151-5.
135. Grimminger F, Mayser P, Papavassilis C, Thomas M, Schlotzer E, Heuer KU et al. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Investig 1993;71:634-43.
136. Chawla A, Karl PI, Fisher SE. Effect of N-3 polyunsaturated fatty acid supplemented diet on neutrophil-mediated ileal permeability and neutrophil function in the rat. J Am Coll Nutr 1995;14:258-63.
137. Zhu BQ, Sievers RE, Sun YP, Morse-Fisher N, Parmley WW, Wolfe CL. Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function? Am Heart J 1994;127(4 Pt 1): 744-55.
138. Otsuji S, Shibata N, Hirota H, Akagami H, Wada A. Highly purified eicosapentaenoic acid attenuates tissue damage in experimental myocardial infarction. Jpn Circ J 1993;57:335-43.
139. Arteaga A, Villanueva CL, Skorin C, Guasch V, Solis de Ovando F, Velasco N et al. Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins [in Spanish]. Rev Med Chil 1993;121:618-25.
140. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller JM et al. N-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI patients: a clinical controlled trial [in Danish]. Ugeskr Laeger 1997;159:5525-9.
141. Omega-3 marine triglycerides. British National Formulary 1998;(35):121.
142. Henderson WR Jr, Astley SJ, McCready MM, Kushmerick P, Casey S. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr 1994;124:400-8.
143. Clarke JT, Cullen-Dean G, Regelink E, Chan L, Rose V. Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil. J Pediatr 1990;116:139-41.
144. Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1990;228:165-71.
145. Eritsland J, Arnesen H, Seljeflot I, Hostmark AT. Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease. Am J Clin Nutr 1995;61 :831-6.
146. Ogden P, Piziak VK, Cain PT, Carpentier WR, Havemann DF. Reactive lymphoid hyperplasia after omega-3 fatty acid supplementation [letter]. Ann Intern Med 1988;109:843-4.
147. Hansen JC, Pedersen HS, Mulvad G. Fatty acids and antioxidants in the inuit diet. Their role in ischemic heart disease (IHD) and possible interactions with other dietary factors. A review. Arctic Med Res 1994;53:4-17.